John T. Bingle
Geen lopende functies
Profiel
John T.
Bingle worked as a Treasurer at Ferro Corp.
from 2016 to 2017 and at Pfanstiehl, Inc. He holds an MBA from Carnegie Mellon University and an undergraduate degree from Rose-Hulman Institute of Technology, Inc.
Eerdere bekende functies van John T. Bingle
| Bedrijven | Functie | Einde |
|---|---|---|
| FERRO CORPORATION | Investor Relations Contact | 20-10-2016 |
Pfanstiehl, Inc.
 Pfanstiehl, Inc. Pharmaceuticals: MajorHealth Technology Pfanstiehl, Inc. develops endotoxin injectable formulation and pharmaceutical ingredients. The firm specializes in isolation, purification, custom synthesis and scale-up development of regulated, high purity and low endotoxin injectable formulation ingredients, pharmaceutical intermediates and active pharmaceutical ingredients. The company was founded by Carl A. Pfanstiehl in 1919 and is headquartered in Waukegan, IL. | Treasurer | - |
Opleiding van John T. Bingle
| Carnegie Mellon University | Masters Business Admin |
| Rose-Hulman Institute of Technology, Inc. | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Ferro Corp.
 Ferro Corp. Industrial SpecialtiesProcess Industries Vibrantz Corp. engages in the business of manufacturing specialty materials. Its products include frits, porcelain and other glass enamels, glazes, stains, decorating colors, pigments, inks, polishing materials, dielectrics, electronic glasses and other specialty coatings. The company was founded by Harry D. Cushman, Raymond Williams, and Henry Luebbert in 1919 and is headquartered in Mayfield Heights, OH. | Process Industries |
Pfanstiehl, Inc.
Pfanstiehl, Inc. Pharmaceuticals: MajorHealth Technology Pfanstiehl, Inc. develops endotoxin injectable formulation and pharmaceutical ingredients. The firm specializes in isolation, purification, custom synthesis and scale-up development of regulated, high purity and low endotoxin injectable formulation ingredients, pharmaceutical intermediates and active pharmaceutical ingredients. The company was founded by Carl A. Pfanstiehl in 1919 and is headquartered in Waukegan, IL. | Health Technology |
